Physician
Wahid, Abdul
Wahid, Abdul was paid $904K by Medicaid between Jan 2018 and Nov 2024, across 27 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 92% of everything it billed.
33Billing provider infoWAHID, ABDUL
BROOKLYN, NY 11212
BROOKLYN, NY 11212
33aNPI1881635498assigned 06/08/2006
33bProvider typeInternal Medicine Physician
28Total paid$904K
24GClaims30,056
24DCodes billed27
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#303 of 6,049
Median peer was paid$11K
This provider vs. median80×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,109 | $22K | |
| 2019 | 2,459 | $22K | |
| 2020 | 2,478 | $44K | |
| 2021 | 5,231 | $117K | |
| 2022 | 5,431 | $184K | |
| 2023 | 6,673 | $248K | |
| 2024incomplete | 5,675 | $266K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 92% | 16,056 | 8,794 | $827K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.7% | 2,204 | 1,754 | $42K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.1% | 727 | 707 | $19K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 234 | 220 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 125 | 109 | $3K |
| 99385 | <1% | 49 | 49 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 44 | 44 | $1K |
| 81000 | <1% | 1,112 | 1,078 | $1K | |
| 90658 | <1% | 128 | 128 | $918.97 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 851 | 833 | $833.56 |
| 99386 | <1% | 13 | 13 | $732.28 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,201 | 969 | $680.85 |
15 more codes
| 86580 | <1% | 69 | $518.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 106 | $478.09 |
| 82042 | <1% | 812 | $372.04 | |
| 93000 | <1% | 16 | $260.34 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 997 | $156.86 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 916 | $56.54 |
| 83700 | <1% | 671 | $9.01 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 151 | $8.36 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 984 | $6.77 |
| 86769 | <1% | 533 | $1.00 | |
| 99000 | 0% | 1,031 | $0.00 | |
| 3008F | 0% | 12 | $0.00 | |
| 3074F | 0% | 12 | $0.00 | |
| 87806 | 0% | 988 | $0.00 | |
| 3078F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.